EATG » Vaccines

Vaccines

HIV viremia, CD4 count determine response to hepatitis A vaccine

Nearly 4% of patients with HIV who received hepatitis A vaccinations during an outbreak demonstrated seroreversion, most of whom had HIV viremia and lower CD4 lymphocyte counts compared with those…

Scientists achieve the first proof of concept for an HIV broadly neutralising antibody vaccine in monkeys

In a step forward in the search for an HIV vaccine, Professor Denis Burton and colleagues from the Scripps Institute in La Jolla, California have manufactured an HIV vaccine that,…

Protection of HIV-1 infected adolescents against HPV-related cancers in Africa

Human Papilloma Virus (HPV) causes virtually all cervical cancers (types 16 and 18 represent 70% of the cases), 95% of anal cancers (mostly by type 16), 70% of oropharyngeal cancers…

HIV vaccine protects non-human primates from infection

LA JOLLA, CA, December 14, 2018 – For more than 20 years, scientists at Scripps Research have chipped away at the challenges of designing an HIV vaccine. Now new research,…

Roadmap reveals shortcut to recreate key HIV antibody for vaccines

With new insights about the antibody's pathway, researchers can bypass a previous hurdle DURHAM, N.C. -- HIV evades the body's immune defenses through a multitude of mutations, and antibodies produced…

Vaccines: our greatest hope in defeating AIDS, Ebola, TB, and other infectious diseases

Doctors, public health officials, and governments are facing what is now the second largest Ebola outbreak in history. The death toll from this latest outbreak in the northeastern region of…

Therapeutic vaccines offer hope for a functional cure for HIV

EU-funded researchers are leading efforts to develop a functional cure for HIV using innovative therapeutic vaccines to halt the progression of the devastating virus, increase the availability and affordability of…

EHVA: European HIV advocates discuss about new clinical study aiming to evaluate experimental strategies for the control of HIV infection

On Thursday, 15th of November, the European AIDS Treatment Group hosted a meeting with members of HIV organisations from six European countries to discuss the launch of the study EHVA…

GeoVax provides update on HIV clinical trials program

Innovative combination vaccine advancing in clinical trials ATLANTA, GA, November 28, 2018 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today provided an update of the…

Scripps Research scientists unveil promising new HIV vaccine strategy

LA JOLLA, CA – A new candidate HIV vaccine from Scripps Research surmounts technical hurdles that stymied previous vaccine efforts, and stimulates a powerful anti-HIV antibody response in animal tests.…

1 2 3 21